Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Mechanisms underlying the neuroprotective effect of brain reserve against late life depression.

Freret T, Gaudreau P, Schumann-Bard P, Billard JM, Popa-Wagner A.

J Neural Transm (Vienna). 2015 Aug;122 Suppl 1:S55-61. doi: 10.1007/s00702-013-1154-2. Epub 2014 Jan 5. Review.

PMID:
24390152
2.

Remodeling of axo-spinous synapses in the pathophysiology and treatment of depression.

Licznerski P, Duman RS.

Neuroscience. 2013 Oct 22;251:33-50. doi: 10.1016/j.neuroscience.2012.09.057. Epub 2012 Oct 2. Review.

3.

Involvement of brain-derived neurotrophic factor in late-life depression.

Dwivedi Y.

Am J Geriatr Psychiatry. 2013 May;21(5):433-49. doi: 10.1016/j.jagp.2012.10.026. Epub 2013 Mar 19. Review.

4.

The neuroprotective effects of estrogen on the aging brain.

Norbury R, Cutter WJ, Compton J, Robertson DM, Craig M, Whitehead M, Murphy DG.

Exp Gerontol. 2003 Jan-Feb;38(1-2):109-17. Review.

PMID:
12543268
5.
6.

Neurobiological and clinical effects of the antidepressant tianeptine.

Kasper S, McEwen BS.

CNS Drugs. 2008;22(1):15-26. Review.

PMID:
18072812
7.
8.

Effects of indole-3-carbinol on clonidine-induced neurotoxicity in rats: Impact on oxidative stress, inflammation, apoptosis and monoamine levels.

El-Naga RN, Ahmed HI, Abd Al Haleem EN.

Neurotoxicology. 2014 Sep;44:48-57. doi: 10.1016/j.neuro.2014.05.004. Epub 2014 May 27.

PMID:
24877722
9.

Chronic depression as a model disease for cerebral aging.

Bewernick BH, Schlaepfer TE.

Dialogues Clin Neurosci. 2013 Mar;15(1):77-85. Review.

10.

Physical activity and brain plasticity in late adulthood.

Erickson KI, Gildengers AG, Butters MA.

Dialogues Clin Neurosci. 2013 Mar;15(1):99-108. Review.

11.

The organization of the stress system and its dysregulation in depressive illness.

Gold PW.

Mol Psychiatry. 2015 Feb;20(1):32-47. doi: 10.1038/mp.2014.163. Epub 2014 Dec 9. Review.

PMID:
25486982
12.

Does neurotropin-3 have a therapeutic implication in major depression?

Pae CU, Marks DM, Han C, Patkar AA, Steffens D.

Int J Neurosci. 2008 Nov;118(11):1515-22. doi: 10.1080/00207450802174589. Review.

PMID:
18853330
13.

New strategies in the development of antidepressants: towards the modulation of neuroplasticity pathways.

Vidal R, Pilar-Cuéllar F, dos Anjos S, Linge R, Treceño B, Vargas VI, Rodriguez-Gaztelumendi A, Mostany R, Castro E, Diaz A, Valdizán EM, Pazos A.

Curr Pharm Des. 2011;17(5):521-33. Review.

PMID:
21375480
14.

Neurobiology of stress, depression, and rapid acting antidepressants: remodeling synaptic connections.

Duman RS.

Depress Anxiety. 2014 Apr;31(4):291-6. doi: 10.1002/da.22227. Epub 2014 Mar 10. Review.

15.

Role of glycogen synthase kinase-3β in ketamine-induced developmental neuroapoptosis in rats.

Liu JR, Baek C, Han XH, Shoureshi P, Soriano SG.

Br J Anaesth. 2013 Jun;110 Suppl 1:i3-9. doi: 10.1093/bja/aet057. Epub 2013 Mar 26.

16.

[Depression and neuroplasticity].

Pitchot W, Polis M, Belachew S, Ansseau M.

Rev Med Liege. 2008 May-Jun;63(5-6):372-7. Review. French.

PMID:
18669207
17.

Resveratrol prevents CA1 neurons against ischemic injury by parallel modulation of both GSK-3β and CREB through PI3-K/Akt pathways.

Simão F, Matté A, Pagnussat AS, Netto CA, Salbego CG.

Eur J Neurosci. 2012 Oct;36(7):2899-905. doi: 10.1111/j.1460-9568.2012.08229.x. Epub 2012 Jul 22.

PMID:
22817531
18.

The neurobiology of depression in later-life: clinical, neuropsychological, neuroimaging and pathophysiological features.

Naismith SL, Norrie LM, Mowszowski L, Hickie IB.

Prog Neurobiol. 2012 Jul;98(1):99-143. doi: 10.1016/j.pneurobio.2012.05.009. Epub 2012 May 17. Review.

PMID:
22609700
19.

Examining the association between late-life depressive symptoms, cognitive function, and brain volumes in the context of cognitive reserve.

O'Shea DM, Fieo RA, Hamilton JL, Zahodne LB, Manly JJ, Stern Y.

Int J Geriatr Psychiatry. 2015 Jun;30(6):614-22. doi: 10.1002/gps.4192. Epub 2014 Aug 22.

20.

Mechanisms mediating brain and cognitive reserve: experience-dependent neuroprotection and functional compensation in animal models of neurodegenerative diseases.

Nithianantharajah J, Hannan AJ.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Mar 30;35(2):331-9. doi: 10.1016/j.pnpbp.2010.10.026. Epub 2010 Nov 26. Review.

PMID:
21112312
Items per page

Supplemental Content

Write to the Help Desk